3625 results for «521»
3625 results
Aortic stenosis doesn't play alone: TAVI in multivalvular and coronary artery disease patients
11 Sep 2025 – From PCR Rio Valves 2025
Managing aortic stenosis becomes even more challenging when it coexists with coronary artery disease (CAD) or multivalvular pathology. For patients with CAD, careful assessment of symptoms, lesion severity, and anatomy guides whether PCI is best performed before, during, or after TAVI, always with future coronary access...
Clinical puzzles in structural interventions
11 Sep 2025 – From PCR Rio Valves 2025
Delve into complex clinical puzzles encountered in structural heart interventions. This session presents comparative outcomes in paradoxical low flow versus high gradient severe aortic stenosis post-TAVI, explores manual and automatic CT measurement techniques, evaluates valve-in-valve procedures within mechanical valves through meta-analysis, and discusses TAVI strategies in...
TAVI cases: the unexpected and the unseen
11 Sep 2025 – From PCR Rio Valves 2025
Explore this session to uncover complex and unexpected challenges encountered during TAVI procedures. Cases include incidental findings such as aortic valve annulus pseudoaneurysm, double coronary artery perforation in severe aortic stenosis, and unique scenarios involving self-expanding valve implantation and transseptal access. Learn strategies for managing bioprosthesis...
Mitral TEER intraprocedural guidance
11 Sep 2025 – From PCR Rio Valves 2025
This session offers a detailed exploration of mitral TEER intraprocedural guidance through case-based learning. It highlights step-by-step techniques, including post-processing and key questions interventionalists face regarding residual regurgitation, clip insertion, and evaluating final procedural outcomes.
Minimalist approach to tricuspid valve therapy
11 Sep 2025 – From PCR Rio Valves 2025
This session highlights the minimalist approach to tricuspid valve therapy with TricValve implantation, a contrast-free, minimally invasive procedure guided by transthoracic echo and minimal fluoroscopy. Clinical evidence shows reduced hospitalisations, improved quality of life, and encouraging mid-term outcomes, including smaller right heart chamber dimensions and reduced...
Innovation session: new techniques and devices in Latin America
11 Sep 2025 – From PCR Rio Valves 2025
Join this innovation-focused session highlighting new structural heart devices and techniques emerging from Latin America. Review real-world cases including mechanical valve re-intervention, TMVR, novel mitral TEER devices, and first clinical experiences with a new self-expandable transcatheter aortic valve in small annuli. Gain valuable procedural and clinical...
Tricuspid and mitral: fine tuning diagnosis and results in transcatheter valve management
11 Sep 2025 – From PCR Rio Valves 2025
This session focuses on refining diagnosis and treatment outcomes in transcatheter management of tricuspid and mitral valves. Topics include assessment of pulmonary artery pressure changes post-MitraClip, 3D echocardiographic evaluation of tricuspid regurgitation severity, quantitative improvements in imaging, and insights from single-centre experiences. Additional discussions cover bicaval...
The complexity of transcatheter tricuspid valve interventions
11 Sep 2025 – From PCR Rio Valves 2025
Explore the complexities of transcatheter tricuspid valve interventions through a series of case studies tackling challenging clinical scenarios. Discover therapeutic options, including TEER in patients with pacemaker leads, imaging strategies with ICE, transcatheter tricuspid valve replacement using Evoque and LuxValve devices, as well as simpler approaches...
Management of hostile access for TAVI
11 Sep 2025 – From PCR Rio Valves 2025
Access challenges are among the most critical hurdles in TAVI procedures. This session explores how to identify difficult access routes using pre-procedural CT, and demonstrates practical techniques to safely overcome these obstacles. Through real-life case presentations—including challenging femoral access with a shockwave balloon, carotid access, and...
Mitral valve - The role of the echocardiography imager pre and post intervention
11 Sep 2025 – From PCR Rio Valves 2025
This session emphasizes the critical role of echocardiography imaging pre- and post-mitral valve interventions. It includes case-based post-processing with comprehensive transthoracic and transesophageal echocardiography essential for decision-making in mitral TEER, identification and grading of recurrent mitral regurgitation, and evaluations related to mitral annular calcification and valve-in-calcification...
Addressing challenges in the right heart
11 Sep 2025 – From PCR Rio Valves 2025
This session addresses complex challenges associated with right heart conditions, featuring cases such as post-infarction interventricular septal defect with right heart failure, innovative orthotopic options for tricuspid regurgitation, and advanced edge-to-edge repair using the TRICLIP device. Gain insight into therapeutic strategies for managing severe tricuspid insufficiency...
Management of aortic stenosis: what really matters before and after the procedure
11 Sep 2025 – From PCR Rio Valves 2025
Aortic stenosis management is a lifetime strategy, not a one-time procedure. This session covers key decision-making factors, compares surgical and transcatheter options, and provides guidance on post-procedural care. Learn to individualise treatment based on age, anatomy, and risk, and plan interventions with the patient’s long-term trajectory...
Problem-solving in challenging TAVI cases
11 Sep 2025 – From PCR Rio Valves 2025
Explore complex and challenging TAVI cases with expert-led discussions covering redo TAVI procedures, horizontal aorta anatomy, rapid pacing protocols, lithotripsy-assisted interventions for severe calcific stenosis, and management of procedural complications including valve dislodgement.
Redefining and optimising LAA closure - LIVE Case
11 Sep 2025 – From PCR Rio Valves 2025
Supported by an unrestricted educational grant from Boston Scientific
A 78-year-old woman with atrial fibrillation and obesity (BMI 34.3), normal left ventricular function, CHADS-VASCs 5 and HAS-BLED 4, presented with severe gastrointestinal bleeding.
She underwent implantation of a Watchman FLX™ pro under local anesthesia via two right femoral...
Seal the deal: echocardioraphy-guided LAA closure for stroke defense
12 Sep 2025 – From PCR Rio Valves 2025
This session focuses on echocardiography-guided left atrial appendage (LAA) closure as a critical strategy for stroke prevention. Attendees will explore optimal cardiac imaging techniques tailored to evolving clinical needs and seasonal considerations. The session also includes comprehensive instruction on post-procedural echocardiographic assessment and post-processing workflows in...
Early outcomes and predictors of success in LATAM TAVI experiences
12 Sep 2025 – From PCR Rio Valves 2025
Explore early outcomes and predictors of success from Latin America's evolving experience with Transcatheter Aortic Valve Implantation (TAVI). This session covers innovative approaches such as transfemoral access intravascular lithotripsy compared to angioplasty, conduction disturbances with self-expandable TAVI devices, and insights from regional centers treating severe aortic...
Mitral challenges: from paravalvular leaks to valve-in-valve
12 Sep 2025 – From PCR Rio Valves 2025
Explore complex mitral valve challenges including paravalvular leaks, valve-in-valve implantation, and comprehensive percutaneous cardiac reconstructions. This session highlights innovative percutaneous solutions for surgical no-go zones, haemolytic leaks, and multi-territory device therapies to improve patient outcomes.
Out-of-the-box TAVI: when anatomy pushes innovation
12 Sep 2025 – From PCR Rio Valves 2025
Witness innovative TAVI applications pushing procedural boundaries in challenging anatomical scenarios. This session reviews cases including bicuspid valves with septal aneurysm, non-calcific aortic regurgitation with complex aortas, decades-old valve treatments, and novel access strategies in severe peripheral artery disease.
TAVI in complex anatomy: high stakes and tight spaces
12 Sep 2025 – From PCR Rio Valves 2025
Address the high-stakes challenges of TAVI in complex anatomical scenarios. This session discusses high-risk valve-in-valve interventions, management of delayed coronary obstruction, procedures in small annuli, and innovative bailout strategies including carotid TAVI.
Management of residual and recurrent mitral regurgitation after TEER
12 Sep 2025 – From PCR Rio Valves 2025
Delve into the complexities of managing residual and recurrent mitral regurgitation following Transcatheter Edge-to-Edge Repair (TEER). This session discusses challenges such as late mitral regurgitation, strategies for handling single leaflet detachment, and anatomical considerations that may preclude TEER feasibility.
